Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant protein inhibitor of complement factor 5 |
---|---|
Date Designated: | 05/10/2016 |
Orphan Designation: | Treatment of Guillain-Barre Syndrome. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Akari Therapeutics Plc 24 West 40th Street 8th Floor New York, New York 10018 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-